Susquehanna International Group
ICPT

Susquehanna International Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Susquehanna International Group’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-206,700
Closed -$3.83M – 13684
2023
Q3 		$3.83M Buy
206,700
+24,400
+13% +$276K ﹤0.01% 3978
2023
Q2 		$2.02M Sell
182,300
-109,800
-38% -$1.53M ﹤0.01% 5145
2023
Q1 		$3.92M Buy
292,100
+116,900
+67% +$2.02M ﹤0.01% 3828
2022
Q4 		$2.17M Sell
175,200
-156,800
-47% -$2.22M ﹤0.01% 4549
2022
Q3 		$4.63M Buy
332,000
+216,300
+187% +$3.48M ﹤0.01% 3283
2022
Q2 		$1.6M Sell
115,700
-99,100
-46% -$1.59M ﹤0.01% 5385
2022
Q1 		$3.5M Buy
214,800
+40,500
+23% +$634K ﹤0.01% 4328
2021
Q4 		$2.84M Sell
174,300
-59,200
-25% -$998K ﹤0.01% 4748
2021
Q3 		$3.47M Buy
233,500
+75,200
+48% +$1.2M ﹤0.01% 4648
2021
Q2 		$3.16M Sell
158,300
-28,200
-15% -$559K ﹤0.01% 4900
2021
Q1 		$4.3M Sell
186,500
-263,500
-59% -$7.35M ﹤0.01% 4204
2020
Q4 		$11.1M Buy
450,000
+224,800
+100% +$7.45M ﹤0.01% 2376
2020
Q3 		$9.34M Buy
225,200
+14,800
+7% +$680K ﹤0.01% 2262
2020
Q2 		$10.1M Buy
210,400
+21,200
+11% +$1.64M ﹤0.01% 2127
2020
Q1 		$11.9M Sell
189,200
-130,000
-41% -$11.7M ﹤0.01% 1570
2019
Q4 		$39.6M Sell
319,200
-123,500
-28% -$11.1M 0.01% 956
2019
Q3 		$29.4M Sell
442,700
-39,500
-8% -$2.65M 0.01% 1062
2019
Q2 		$38.4M Sell
482,200
-14,600
-3% -$1.31M 0.01% 827
2019
Q1 		$55.6M Sell
496,800
-110,800
-18% -$12.1M 0.02% 574
2018
Q4 		$61.2M Buy
607,600
+24,200
+4% +$2.51M 0.02% 527
2018
Q3 		$73.7M Buy
583,400
+204,300
+54% +$21.6M 0.02% 534
2018
Q2 		$31.8M Sell
379,100
-94,000
-20% -$6.88M 0.01% 947
2018
Q1 		$29.1M Sell
473,100
-45,300
-9% -$2.73M 0.01% 960
2017
Q4 		$30.3M Sell
518,400
-416,100
-45% -$26.2M 0.01% 972
2017
Q3 		$54.2M Buy
934,500
+700,000
+299% +$75.4M 0.02% 603
2017
Q2 		$28.4M Sell
234,500
-27,200
-10% -$3.15M 0.01% 902
2017
Q1 		$29.6M Sell
261,700
-349,800
-57% -$40.8M 0.02% 823
2016
Q4 		$66.4M Buy
611,500
+147,200
+32% +$17.5M 0.03% 457
2016
Q3 		$76.4M Sell
464,300
-53,400
-10% -$8.42M 0.04% 391
2016
Q2 		$73.9M Buy
517,700
+100,900
+24% +$14.7M 0.04% 386
2016
Q1 		$53.5M Buy
416,800
+29,100
+8% +$3.44M 0.03% 499
2015
Q4 		$57.9M Buy
387,700
+27,900
+8% +$4.72M 0.03% 546
2015
Q3 		$59.7M Sell
359,800
-69,400
-16% -$15.3M 0.03% 545
2015
Q2 		$104M Sell
429,200
-126,500
-23% -$33.7M 0.04% 385
2015
Q1 		$157M Buy
555,700
+118,500
+27% +$25.7M 0.07% 241
2014
Q4 		$68.2M Sell
437,200
-74,400
-15% -$13.7M 0.03% 564
2014
Q3 		$121M Buy
511,600
+51,500
+11% +$13.1M 0.05% 357
2014
Q2 		$109M Buy
+460,100
New +$121M 0.05% 349

Susquehanna International Group's ICPT Position: Q4 2023 in Review

Susquehanna International Group sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 366,014 shares — an estimated $6.79M sold.

Susquehanna International Group first reported a position in ICPT in Q3 2013 and held it in 40 quarters. The position peaked at $74.9M in Q3 2014. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

  • Susquehanna International Group reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
  • Susquehanna International Group sold 366,014 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $6.79M.
  • Susquehanna International Group first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2013 and held it in 40 quarters.
  • Susquehanna International Group's Intercept Pharmaceuticals, Inc. position peaked at $74.9M in Q3 2014.
  • 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.